Parallel Session I: Epidemiology

Age and Time-Dependent Increase i Incident Anti-Glomerular Basement Membrane (Anti-GBM) Disease – A Nationwide Cohort Study

Dr. Karl Nelveg-Kristensen

#Vasculitis22
What do we know about anti GBM disease?

#Vasculitis22
Retrospective cohort study

Anti-GBM identified by ICD10 code.

Denmark

#Vasculitis22
Results

Baseline characteristics

#Vasculitis22
Subgroup analysis of double positivity.

Slight predominance of MPO; also older and more often female.

#Vasculitis22
Incidence increasing over time.

Bimodal age distribution.

More lung haemorrhage in younger male population.

#Vasculitis22
What about mortality?

See below:

#Vasculitis22
Conclusions

Increasing incidence over time period.

Bimodal age distribution.

Double positivity behaves differently.

Mortality is high

#Vasculitis22

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Vasculitis 2022

Vasculitis 2022 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Vasculitis2022

Apr 5
Parallel Session V: Outcomes

Cardiovascular Burden in Patients With ANCA-Associated and Non-ANCA Associated Vasculitis

Dr. Ana B Arevalo

@ANABELENAREVAL2

#Vasculitis22
Retrospective cohort study

AAV and non ANCA associated vasculitis compared

CV outcomes of interest.

#Vasculitis22 ImageImageImage
AAV higher risk of mortality even when adjusted for potential confounders.

#Vasculitis22 Image
Read 4 tweets
Apr 5
Parallel Session V: Outcomes

Outcomes in ANCA-Associated Vasculitis: Validating a Renal Risk Score and Examining the Impact of Deprivation

Dr. Dominic McGovern

@DomP_McGovern

#Vasculitis22
Large national cohort in Scotland

All renal biopsies in Scotland from 2014-2020 included.

EGPA and double positivity excluded.

#Vasculitis22 Image
Renal risk score was good at differentiating ESKD outcomes and prediction of relapse.

#Vasculitis22 ImageImage
Read 5 tweets
Apr 5
Parallel Session V: Outcomes

Malignancies in Patients with AAV Treated Within the EUVAS Trials

Dr. Beatriz Sánchez Álamo

#Vasculitis22
Future cancer risk is a concern with immunosuppression for AAV.

ncbi.nlm.nih.gov/pmc/articles/P…

#Vasculitis22
Aims of this were to analyse results from extended follow up of patients who participated in EUVAS prospective RCTs.

#Vasculitis22 ImageImage
Read 7 tweets
Apr 5
Parallel Session V: Outcomes

Neurologic Involvement in Anca-Associated Vasculitis: Data From Multicenter Longitudinal Observational Study

Prof. Rula Hajj-Ali

@RulaHajjAliMD

#Vasculitis22
Neurological involvement is common in AAV but has a variable presentation and not well studied.

#Vasculitis22 ImageImage
Aims and methods

#Vasculitis22 ImageImage
Read 6 tweets
Apr 5
Parallel Session IV: Paediatric Vasculitis
Monogenic Mimics of Behçet’s Disease

Dr Alice Burleigh

@burleigh_alice

#Vasculitis22
More Monogenic Mimics of Behçet’s Disease have been reported recently but not thoroughly investigated

Aim and 1-slide method

#Vasculitis22 ImageImage
Going on to the findings

#Vasculitis22 ImageImage
Read 4 tweets
Apr 5
Parallel Session IV: Paediatric Vasculitis

Characteristics of Pediatric ANCA Associated Vasculitis Among Racial/Ethnic Minorities- single center experience from United States

Dr Deepika Singh
#Vasculitis22
The aim of this study was to study the characteristics of pediatric patients from racial/ethnic minorities with AAV

1-slide methods

#Vasculitis22 Image
Going on to the results

#Vasculitis22 ImageImageImageImage
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(